Osteocyte CIITA aggravates osteolytic bone lesions in myeloma.

MLA

Liu, Huan, et al. “Osteocyte CIITA Aggravates Osteolytic Bone Lesions in Myeloma.” Nature Communications, vol. 13, no. 1, June 2022, p. 3684. EBSCOhost, https://doi.org/10.1038/s41467-022-31356-7.

APA

Liu, H., He, J., Bagheri-Yarmand, R., Li, Z., Liu, R., Wang, Z., Bach, D.-H., Huang, Y.-H., Lin, P., Guise, T. A., Gagel, R. F., & Yang, J. (2022). Osteocyte CIITA aggravates osteolytic bone lesions in myeloma. Nature Communications, 13(1), 3684. https://doi.org/10.1038/s41467-022-31356-7

Chicago

Liu, Huan, Jin He, Rozita Bagheri-Yarmand, Zongwei Li, Rui Liu, Zhiming Wang, Duc-Hiep Bach, et al. 2022. “Osteocyte CIITA Aggravates Osteolytic Bone Lesions in Myeloma.” Nature Communications 13 (1): 3684. doi:10.1038/s41467-022-31356-7.